Withdrawn From Com
Summary
The bill creates the Breakthrough Therapies Research Grant Fund to award up to five $1 million competitive grants for three‑year studies on psychedelic drugs such as ibogaine, MDMA, and psilocybin. It also forms a multi‑agency Breakthrough Therapies Task Force to evaluate the use of these medicines, recommend licensing and insurance rules, and guide future legal pathways. The measure targets research institutions in North Carolina and aims to improve mental‑health treatment for veterans, first responders, frontline health workers, and survivors of domestic violence or sexual assault.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1018 changes status, plus AI-powered summaries and stage predictions.
Sign up free